Sfoglia per Rivista CARDIOVASCULAR DRUGS AND THERAPY
Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management
2019-01-01 Correale, M.; Tricarico, L.; Grazioli, D.; Formica, E. S.; Petrucci, R.; Persichella, P.; Di Biase, M.; Brunetti, N. D.
Effects of isradipine sustained release on patelet function and fibrinolysis in essential hypertensives with or without other rish factors
1996-01-01 Ranieri, G; Filitti, V; Andriani, A; Bonfantino, M. V.; DE CESARIS, Raffaele
The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic
2021-01-01 Correale, M.; Croella, F.; Leopizzi, A.; Mazzeo, P.; Tricarico, L.; Mallardi, A.; Fortunato, M.; Magnesa, M.; Ceci, V.; Puteo, A.; Iacoviello, M.; Di Biase, M.; Brunetti, N. D.
Hemodynamic study of intravenous propionyl-L-carnitine in patients with ischemic heart disease and normal left ventricular function.
1991-01-01 Chiddo, A; Gaglione, Antonio; Musci, S; Troito, G; Grimaldi, N; Locuratolo, N; Rizzon, P.
Hemostatic variables and ischemic cardiovascular disease: do we need a concerted effort for more profitable future clinical investigations?
1997-01-01 Di Minno, G; Mancini, Fp; Margaglione, Maurizio
Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies
2020-01-01 Brunetti, N. D.; Tricarico, L.; Tilz, R. R.; Heeger, C. -H.; De Gennaro, L.; Correale, M.; Ieva, R.; Di Biase, M.; Rillig, A.; Metzner, A.; Santoro, F.
Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure
2021-01-01 Correale, M.; Mazzeo, P.; Mallardi, A.; Leopizzi, A.; Tricarico, L.; Fortunato, M.; Magnesa, M.; Tucci, S.; Maiellaro, P.; Pastore, G.; Lamacchia, O.; Iacoviello, M.; Di Biase, M.; Brunetti, N. D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management | 1-gen-2019 | Correale, M.; Tricarico, L.; Grazioli, D.; Formica, E. S.; Petrucci, R.; Persichella, P.; Di Biase, M.; Brunetti, N. D. | |
| Effects of isradipine sustained release on patelet function and fibrinolysis in essential hypertensives with or without other rish factors | 1-gen-1996 | Ranieri, G; Filitti, V; Andriani, A; Bonfantino, M. V.; DE CESARIS, Raffaele | |
| The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic | 1-gen-2021 | Correale, M.; Croella, F.; Leopizzi, A.; Mazzeo, P.; Tricarico, L.; Mallardi, A.; Fortunato, M.; Magnesa, M.; Ceci, V.; Puteo, A.; Iacoviello, M.; Di Biase, M.; Brunetti, N. D. | |
| Hemodynamic study of intravenous propionyl-L-carnitine in patients with ischemic heart disease and normal left ventricular function. | 1-gen-1991 | Chiddo, A; Gaglione, Antonio; Musci, S; Troito, G; Grimaldi, N; Locuratolo, N; Rizzon, P. | |
| Hemostatic variables and ischemic cardiovascular disease: do we need a concerted effort for more profitable future clinical investigations? | 1-gen-1997 | Di Minno, G; Mancini, Fp; Margaglione, Maurizio | |
| Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies | 1-gen-2020 | Brunetti, N. D.; Tricarico, L.; Tilz, R. R.; Heeger, C. -H.; De Gennaro, L.; Correale, M.; Ieva, R.; Di Biase, M.; Rillig, A.; Metzner, A.; Santoro, F. | |
| Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure | 1-gen-2021 | Correale, M.; Mazzeo, P.; Mallardi, A.; Leopizzi, A.; Tricarico, L.; Fortunato, M.; Magnesa, M.; Tucci, S.; Maiellaro, P.; Pastore, G.; Lamacchia, O.; Iacoviello, M.; Di Biase, M.; Brunetti, N. D. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile